- Home
- SSRM vs SUPN Comparison
SSRM vs SUPN Comparison
Compare SSRM & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- SUPN
- Stock Information
- Founded
- SSRM 1946
- SUPN 2005
- Country
- SSRM United States
- SUPN United States
- Employees
- SSRM N/A
- SUPN N/A
- Industry
- SSRM Precious Metals
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- SSRM Industrials
- SUPN Health Care
- Exchange
- SSRM Nasdaq
- SUPN Nasdaq
- Market Cap
- SSRM 2.2B
- SUPN 1.9B
- IPO Year
- SSRM 1996
- SUPN 2012
- Fundamental
- Price
- SSRM $13.16
- SUPN $32.07
- Analyst Decision
- SSRM Hold
- SUPN Hold
- Analyst Count
- SSRM 3
- SUPN 2
- Target Price
- SSRM $10.53
- SUPN $36.00
- AVG Volume (30 Days)
- SSRM 3.3M
- SUPN 672.8K
- Earning Date
- SSRM 07-30-2025
- SUPN 08-05-2025
- Dividend Yield
- SSRM N/A
- SUPN N/A
- EPS Growth
- SSRM N/A
- SUPN N/A
- EPS
- SSRM 0.42
- SUPN 1.11
- Revenue
- SSRM $1,082,002,000.00
- SUPN $667,997,000.00
- Revenue This Year
- SSRM $40.21
- SUPN N/A
- Revenue Next Year
- SSRM $19.05
- SUPN $12.02
- P/E Ratio
- SSRM $30.53
- SUPN $28.93
- Revenue Growth
- SSRM N/A
- SUPN 11.82
- 52 Week Low
- SSRM $4.32
- SUPN $25.55
- 52 Week High
- SSRM $13.46
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- SSRM 61.30
- SUPN 49.97
- Support Level
- SSRM $12.04
- SUPN $30.93
- Resistance Level
- SSRM $12.67
- SUPN $32.78
- Average True Range (ATR)
- SSRM 0.48
- SUPN 1.01
- MACD
- SSRM -0.05
- SUPN -0.06
- Stochastic Oscillator
- SSRM 78.87
- SUPN 50.20
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.